Eargo 7 vs Otofonix Encore

The Eargo 7 is a premium-priced OTC hearing aid at $2,550, featuring an invisible-in-ear design with rechargeable batteries. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.5/5, placing it in the top 57% of the OTC hearing aid category. Speech performance in quiet environments is a strength for the Eargo 7, scoring 3.1/5—0.33 points above the category average. Own-voice comfort also exceeds the category average by 0.39 points, though at 2.9/5 it remains mixed in absolute terms. However, speech understanding in noisy environments presents a limitation, scoring 1.0/5, which falls 0.44 points below the category average. A significant drawback is the complete absence of music streaming capability, scoring 0.0/5—nearly 2 points below the category average. Feedback handling is solid at 3.8/5 in absolute terms, though it falls 0.74 points below the category average for OTC devices. The Eargo 7 may appeal to users who prioritize a discreet, nearly invisible form factor and primarily need assistance in quieter listening situations. However, consumers seeking strong noise performance or music streaming should be aware of these limitations, particularly given the premium price point. Several alternatives at lower price points achieve higher overall scores in our testing.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.